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BACKGROUND. There has been much controversy surrounding the biologic behav-
ior and prognosis of early stage gastric signet ring cell carcinoma (SRC). To clarify
the biologic behavior of early stage gastric SRC (early SRC), we compared the
clinicopathologic features and prognosis of early SRC with other histologic types.
METHODS. A total of 933 patients with early gastric carcinoma who had undergone
gastrectomy from 1987 to 1995 were retrospectively analyzed. Among them, 263
patients with SRC were compared to 670 patients with other histologic types.
RESULTS. Younger patients more often had SRC than non-SRC. Additionally, the
proportion of females was greater in SRC than in non-SRC. Signet ring cell carci-
noma had a larger proportion of mucosa-confined lesions and a lower rate of
lymph node metastasis than non-SRC. Even after stratifying the clinicopathologic
characteristics, SRC showed a lower rate of lymph node metastasis than non-SRC.
When the lymph node metastasis rate was compared between SRC and undiffer-
entiated histology other than SRC, SRC demonstrated a lower lymph node metas-
tasis rate. Multivariate analysis showed that SRC histology was a negative inde-
pendent risk factor for lymph node metastasis in early gastric carcinoma. The
prognosis of SRC was significantly better than that of non-SRC (P  0.0104).
CONCLUSIONS. Early gastric carcinoma with SRC is a distinct type of gastric carci-
noma in terms of clinicopathologic features and prognosis. The favorable progno-
sis and lower rate of lymph node metastasis in early SRC suggest that the patients
with early gastric carcinoma with SRC could be candidates for less invasive sur-
geries for an improved quality of life. Cancer 2002;94:78 – 83.
© 2002 American Cancer Society.
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According to World Health Organization (WHO) classification, gas-tric signet ring cell carcinoma (SRC) is a histologic type, primarily
based on the microscopic characteristics of the tumor but not on the
biologic behavior.1 SRC has been classified as “diffuse type” by Lau-
ren,2 “infiltrative type” by Ming,3 and “undifferentiated type” by
Sugano et al.4 To establish a scale of tumor aggressiveness related to
prognosis, the WHO1 and the Union International Contra la Cancrum
(UICC)5 adapted a grading system in which SRC has been classified as
high grade.
Although there have been studies of the clinicopathologic char-
acteristics including prognosis of SRC, the results were not consistent.
To our knowledge, no study has focused on early stage SRC (early
SRC).6 –9 Furthermore, few treatment strategies specific to histology
for gastric carcinoma have been developed, especially for SRC, while
the various types of newly developed treatment modalities have been
introduced.
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The purpose of this study was to clarify the bio-
logic behavior of the early SRC by comparing the
clinicopathologic features, including prognosis, with
other histologic types of early gastric carcinoma. In
addition, we also analyzed and compared the patterns
of lymph node metastasis in patients with early SRC
with other histologic types to find out the applicability
of less invasive surgery for early SRC.
PATIENTS AND METHODS
A total of 3,104 patients who had undergone gastrec-
tomy for histologically-proven gastric adenocarci-
noma at the Department of Surgery, Yonsei University
College of Medicine from January 1987 to December
1995 were reviewed retrospectively. Among the study
population, 556 patients (17.9%) had SRC histology;
the remaining 2548 patients (82.1%) had non-SRC his-
tology. Of these 3104 patients, 933 patients had early
gastric carcinoma. Among these 933 patients, 263
(28.2%) had early gastric carcinomas with SRC histo-
logic type and 670 (71.8%) had early gastric carcinoma
with non-SRC histologic type. Among 670 patients
with non-SRC histology early gastric carcinoma, 248
(26.6% of all early gastric carcinoma patients) had
early gastric carcinoma with undifferentiated histol-
ogy other than SRC (poorly differentiated or mucinous
adenocarcinoma). Patient follow-up lasted until death
or until the cut-off date of June 30, 2000. At the time of
the last follow-up, 44 patients (4.7%) had been lost to
follow-up. The median follow-up interval for the 773
patients alive at the cut-off date was 84 months (range
54-161 months).
We followed the criteria of the WHO classification
for histologic typing of gastric tumors: SRC was de-
fined as “an adenocarcinoma in which a predominant
component (more than 50% of the tumor) is made up
of isolated or small groups of malignant cells contain-
ing intracytoplasmic mucin.”1 Pathologic features that
might potentially influence prognosis (location and
size of the primary tumor, macroscopic types, depth of
invasion, and nodal status) were analyzed. Other vari-
ables analyzed included age, gender, type of opera-
tion, and stage by the fifth tumor node metastasis
system of UICC.5 The nodal status was evaluated using
both number and extent of lymph node involve-
ment.10
The following standardized operative procedures
were performed: 1) A total or distal subtotal gastrec-
tomy was performed depending on the location and
macroscopic type of gastric carcinoma ; 2) D2 lymph-
adenectomy was preferred according to the rules of
“The Japanese Research Society for Gastric Cancer.”11
Statistical Analysis
All the statistical analyses were performed using the
statistical software Statistical Package for Social Sci-
ence (SPSS) version 9.0 for Windows (SPSS, Inc, Chi-
cago, IL).12The inter-group comparisons of clinico-
pathologic variables were made using the two-tailed
chi-square test for discrete variables.
The rates of lymph node metastasis were com-
pared between SRC and non-SRC after stratifying the
clinicopathologic characteristics. Risk factors influ-
encing lymph node metastasis were determined by
logistic regression analysis. The odds ratio in the mul-
tivariate analysis was defined as the ratio of the prob-
ability that an event (lymph node metastasis) would
occur to the probability that it would not occur. The
prognostic power of covariates was expressed by cal-
culation of an odds ratio with a 95% confidence inter-
val.
The lost cases and operative mortality cases were
treated as censored data for the analysis of survival
rates. The Kaplan-Meier method13 was used for calcu-
lating the survival rate and the difference between the
curves was assessed using the log-rank test. The ac-
cepted level of significance was P  0.05.
RESULTS
The incidence of SRC was 17.9% of the total cases of
gastrectomies performed (556 patients out of 3104).
Signet ring cell carcinoma had a higher prevalence of
early gastric carcinoma (47.3%, 263 patients out of
556) than non-SRC (26.3%, 670 patients out of 2548).
The incidence of early SRC was 28.2% of all early
gastric carcinoma. Signet ring cell carcinoma was
more common in younger patients than non-SRC. The
proportion of females in the group with SRC was
larger than in non-SRC (Table 1).
Signet ring cell carcinoma had a larger proportion
of mucosa-confined and mid body located lesions
than non-SRC among early gastric carcinoma patients.
A depressed lesion was the most common macro-
scopic type of SRC. Signet ring cell carcinoma showed
a significantly lower lymph node metastasis rate
(5.7%) than non-SRC (16.0%) (P 0.001). Nodal status
evaluated by number and extent of lymph node in-
volvement in SRC was significantly more favorable
than in non-SRC (Table 1).
In a univariate analysis, tumor size, macroscopic
type, depth of invasion, and histologic type showed a
significant difference in lymph node metastasis (Table
2). When lymph node metastasis was compared be-
tween SRC and non-SRC after stratifying the clinico-
pathologic variables, patients with SRC showed less
lymph node metastasis than patients with non-SRC at
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all variables (Fig 1). Only 1.6% of the patients with SRC
confined to mucosa showed lymph node metastasis,
and all the involved lymph nodes were exclusively
perigastric nodes, whereas 3.5% of the patients with
non-SRC confined to mucosa showed lymph node
metastasis. When tumors invaded the submucosal
layer, the lymph node metastasis rate of SRC was
15.4%, while that of non-SRC was 25.5%. Tumors
less than 1 cm in diameter with SRC histology
showed no lymph node metastasis. Lymph node
metastasis rates of SRC were similar and less than
8%, regardless of tumor size, while those of non-SRC
increased up to 26.8% when tumors were larger than
2cm (Fig. 1).
In a comparison of lymph node metastasis rates
between SRC and undifferentiated histology other
than SRC (poorly differentiated or mucinous adeno-
carcinoma) according to clinicopathologic features,
less lymph node metastasis rates, were noted in SRC at
all variables (Fig. 2).
Multivariate analysis using logistic regression
analysis showed that male gender, a larger tumor size,
submucosal invasion, and non-SRC histology were in-
dependent risk factors for lymph node metastasis (Ta-
ble 3).
The cumulative survival was significantly higher
in patients with SRC histology than those with non-
SRC histology (P  0.0104). The 5-year and 10-year
survival rates were 94.2% and 89.7% for patients with
SRC histology, 91.6% and 79.1% for those with non-
SRC histology (Fig. 3).
TABLE 1
Comparative Data on Early Gastric Cancer Patients
Clinicopathologic
features
SRC
n  263 (%)
non-SRC
n  670 (%) P value
Age (yrs)  0.001
 55 184 (70.0) 276 (41.2)
 55 79 (30.0) 394 (58.8)
Gender  0.001
Male 140 (53.2) 466 (69.6)
Female 123 (46.8) 204 (30.4)
Location 0.042
Lower 120 (45.6) 367 (54.8)
Middle 126 (47.9) 266 (39.7)
Upper 17 (6.5) 37 (5.5)
Operation 0.123
Total 40 (15.2) 77 (11.5)
Subtotal 223 (84.8) 593 (88.5)
Tumor size (cm) 0.379
 1.0 20 (7.6) 77 (11.5)
 2.0 74 (28.1) 189 (28.2)
 3.0 60 (22.8) 147 (21.9)
 4.0 40 (15.2) 108 (16.1)
 4.0 69 (26.2) 149 (22.2)
Macroscopic type  0.001
Elevated 24 (9.1) 174 (26.0)
Flat 39 (14.8) 83 (12.4)
Depressed 200 (76.1) 413 (61.6)
Depth of invasion  0.001
Mucosa 185 (70.3) 289 (43.1)
Submucosa 78 (29.7) 381 (56.9)
LN metastasis  0.001
Negative 248 (94.3) 563 (84.0)
Positive 15 (5.7) 107 (16.0)
Extent of LN metastasisa  0.001
N0 248 (94.3) 563 (84.0)
N1 12 (4.9) 76 (11.3)
N2 3 (0.8) 24 (3.6)
N3 0 (0.0) 7 (1.0)
Number of involved LNs  0.001
0 248 (94.3) 563 (84.0)
1–2 9 (3.4) 54 (8.4)
3–4 3 (1.1) 23 (3.4)
 5 3 (1.1) 30 (4.5)
SRC: Signet ring cell carcinoma; LN: lymph node.
a Based on 4th UICC classification.
TABLE 2
Comparative Data on Lymph Node Metastasis in Early Gastric
Cancer Patients
Clinicopathologic
features
Lymph node metastasis
P value
Negative
n  811
Positive
n  122
% of
Positive
Age (yrs) 0.165
 55 407 53 11.5
 55 404 69 14.6
Gender 0.060
Male 536 70 11.6
Female 275 52 15.9
Location 0.443
Lower 422 65 13.3
Middle 339 53 13.5
Upper 50 4 7.4
Tumor size (cm)  0.001
 1.0 91 6 6.2
 2.0 246 17 6.5
 3.0 175 32 15.5
 4.0 125 23 15.5
 4.0 174 44 20.2
Macroscopic type 0.001
Elevated 158 40 20.2
Flat 114 8 6.6
Depressed 539 74 12.1
Depth of invasion  0.001
Mucosa 461 13 2.7
Submucosa 350 109 23.7
Histological type  0.001
SRC 248 15 5.7
non-SRC 563 107 16.0
SRC: Signet ring cell carcinoma.
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DISCUSSION
The main findings of this study are: 1) early gastric
carcinoma with SRC histology had a larger proportion
of mucosa-confined, midbody located, depressed le-
sions and a lower rate of lymph node metastasis than
non-SRC; and 2) patients with SRC histology showed a
better survival rate than patients with non-SRC.
A higher prevalence in female patients and in
younger patients and predominance of macroscopi-
cally depressed lesions are consistent characteristics
of early SRC compared to previous studies. Distribu-
tion of depth of invasion and lymph node metastasis,
which are important prognostic factors, are inconsis-
tent with previous studies. These contradictory results
may arise through small sample sizes of patients with
early SRC, lack of accurate staging of patients, or in-
adequate interpretation of statistical analysis.6 –9 Sugi-
hara et al. suggested that SRC forms more frequently
in the intramucosal section than the extramucosal
section of the lesion.14 A higher proportion of de-
pressed lesions and easily detectable histologic fea-
tures of enriched intracytoplasmic mucin with periph-
erally compressed nucleus enables early detection of
SRC by an endoscopic exam and biopsy.8 In a study of
clarifying the significance of the intestinalization in
the growth of signet ring cell carcinoma, the expres-
sion of the intestinal phenotype is a time-dependent
and unstable phenomenon probably based on the ac-
cumulation of genetic changes; this intestinal pheno-
type expression plays a role in progression of signet
ring cell carcinomas as the depth of invasion pro-
ceeds.15 These biologic and histologic natures of SRC
could be the reasons for a larger proportion of mucosa-
confined lesions in early SRC.
Another peculiar characteristic of early SRC is the
pattern of lymph node metastasis. Early SRC had low
probabilities of lymph node metastasis, and no early
SRC smaller than 1cm in tumor size had lymph node
metastasis. Unlike other histologic types, the lymph
node metastasis rate of SRC did not increase as the
size of the tumor increased. Only 1.6% of early SRC
confined to mucosa showed lymph node metastasis,
and all the involved lymph nodes were perigastric
nodes. Signet ring cell carcinoma-invaded submuco-
sal layer also showed less lymph node metastasis
(15.4%) than non-SRC (25.5%). SRC histology was neg-
atively associated with lymph node metastasis in a
multivariate analysis. Therefore, a patient with early
SRC histology would be a good candidate for less
invasive surgery.
To our knowledge, no study had attempted to
clarify the applicability of less invasive surgery for
early SRC, despite the previous studies on clinicopath-
ologic features or biologic behavior of SRC. As SRC
was classified as undifferentiated or diffuse type in
many studies about less invasive surgeries, SRC was
considered a histologic type of contraindication or a
limited indication for the application of less invasive
surgery.16 –18 In this study, SRC showed a significantly
lower lymph node metastasis rate than undifferenti-
ated histology other than SRC.
Japanese researchers have reported that the prog-
nosis of early gastric carcinoma with SRC was signifi-
cantly better than that of other types,6,8 while Kim et
al.7 reported that prognosis of early gastric carcinoma
with SRC patients was similar to other types of carci-
nomas. In the current study, the survival rate in pa-
tients with early SRC was higher than that in patients
FIGURE 1. Histogram showing the rate of lymph node metastasis according
to clinicopathologic features in early gastric carcinomas with or without signet
ring cell carcinoma (SRC) histology. Tumors with SRC histology show a lower
lymph node metastasis rate after stratifying all clinicopathologic variables.
FIGURE 2. Histogram showing the rate of lymph node metastasis according
to clinicopathologic features in early gastric carcinomas with signet ring cell
carcinoma (SRC) histology or with undifferentiated histology other than SRC
(Undiff. other than SRC). Tumors with SRC histology show a lower lymph node
metastasis rate after stratifying all clinicopathologic variables.
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without SRC. The better prognosis of early SRC than
non-SRC is related to a lower lymph node metastasis
rate and a higher prevalence of mucosa-confined le-
sions in SRC.
Advanced gastric carcinoma with SRC is charac-
terized by the potential to infiltrate the gastric wall
diffusely and a unique type of SRC, linitis platisca,
which indicates carcinomas involving the entire stom-
ach, a higher rate of peritoneal dissemination than
non-SRC.19,20 Advanced gastric carcinoma with SRC
showed a rate of lymph node metastasis similar to or
higher than other types of carcinoma.6 – 8 Unlike ad-
vanced cancer, early gastric carcinoma with SRC has
characteristics of favorable clinicopathologic features
and good prognosis.
Taking into consideration the clinicopathologic
features and prognosis, we suggest that early signet
ring cell carcinoma of the stomach should be regarded
as a distinct type of gastric carcinoma. Based on these
results, early SRC can be a candidate for less invasive
surgery for an improved quality of life.
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